Cambrian (688256.SH) is expected to grow its revenue by 50.83% to 69.16% and narrow its loss by 42.95% to 53.33% in 2024, while focusing on AI product research and development innovation.
Cambrian (688256.SH) announced that, according to preliminary calculations by the financial department, it is expected to achieve operating... in 2024.
Huanwuji (688256.SH) announced that, according to the preliminary calculation by the finance department, it is expected to achieve a business income of 1.07 billion to 1.2 billion yuan in 2024, an increase of 360.61 million to 490.61 million yuan compared to the same period last year, representing a growth of 50.83% to 69.16%.
The net profit attributable to the owners of the parent company is expected to incur a loss in 2024, with a projected loss of 396 million to 484 million yuan, a narrowing of 364.44 million to 452.44 million yuan compared to the same period last year, representing a decrease of 42.95% to 53.33%.
The net profit attributable to the owners of the parent company after deducting non-recurring gains and losses is expected to incur a loss of 765 million to 935 million yuan in 2024, a narrowing of 107.86 million to 277.86 million yuan compared to the same period last year, representing a decrease of 10.34% to 26.64%.
The company has always focused on the research and technological innovation of artificial intelligence chip products. During the reporting period, the company continued to expand its market and actively supported the implementation of artificial intelligence applications, leading to a significant increase in revenue compared to the same period last year. The impact of non-recurring gains and losses on net profit during the reporting period is expected to be between 369 million and 451 million yuan, mainly due to the reversal of bad debt provisions and the impact of government subsidies accounted for as income in the current period.
Related Articles

HK Stock Market Move | "Three oil giants" active in the morning session, CNOOC (00883) up over 3%, and PetroChina (00857) up nearly 2%.

HK Stock Market Move | GIANT BIOGENE (02367) rebounds by more than 8%, controlling shareholder increases holdings by 500,000 shares, Citigroup says market's reaction to presale performance is exaggerated.

HK Stock Market Move | Li Ning (02331) rises more than 4% and announces its entry into the Meituan Flash Purchase platform, laying out its instant retail channel.
HK Stock Market Move | "Three oil giants" active in the morning session, CNOOC (00883) up over 3%, and PetroChina (00857) up nearly 2%.

HK Stock Market Move | GIANT BIOGENE (02367) rebounds by more than 8%, controlling shareholder increases holdings by 500,000 shares, Citigroup says market's reaction to presale performance is exaggerated.

HK Stock Market Move | Li Ning (02331) rises more than 4% and announces its entry into the Meituan Flash Purchase platform, laying out its instant retail channel.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025